— Know what they know.
Not Investment Advice

MBIO NASDAQ

Mustang Bio, Inc.
1W: -9.5% 1M: -13.2% 3M: -33.6% YTD: -56.0% 1Y: -70.0% 3Y: -99.5% 5Y: -100.0%
$0.47
+0.00 (+0.83%)
 
Weekly Expected Move ±7.4%
$0 $0 $0 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $3.6M mcap · 6M float · 1.55% daily turnover · Short 15% of daily vol

Balance Sheet Trends

Total Assets
$18M +89.0% ▲
5Y CAGR: -30.7%
Total Liabilities
$8M -38.8% ▼
5Y CAGR: -6.8%
Shareholders Equity
$10M +346.0% ▲
5Y CAGR: -37.3%
Cash & Investments
$17M +152.5% ▲
5Y CAGR: -29.3%
Total Debt
$0 -100.0% ▼
Net Debt
-$17M -189.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$110M$76M$6M$7M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$110M$76M$6M$7M$17M
Net Receivables$50K$0$4M$402K$217K
Inventory$0$0$0$0$0
Other Current Assets$0$299K$1M$1M$110K
Total Current Assets$112M$79M$11M$9M$18M
Property, Plant & Equip.$12M$12M$5M$452K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$1M$1M$2M$250K$0
Total Non-Current Assets$13M$14M$6M$702K$0
Total Assets$125M$92M$18M$9M$18M
— Liabilities —
Accounts Payable$4M$7M$6M$7M$4M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$150K
Other Current Liabilities$3M$648K$3M$93K$4M
Total Current Liabilities$11M$15M$15M$13M$8M
Long-Term Debt$0$27M$0$0$0
Other Non-Current Liab.$0$270K$0$0$0
Total Non-Current Liabilities$2M$31M$2M$572K$150K
Total Liabilities$13M$46M$18M$13M$8M
— Equity —
Common Stock$9K$11K$1K$5K$1K
Retained Earnings-$252M-$329M-$381M-$397M-$399M
Accumulated OCI$0$1M$0$0$273K
Total Stockholders Equity$112M$46M$123K-$4M$10M
Total Liabilities & Equity$125M$92M$18M$9M$18M
— Key Metrics —
Total Debt$2M$31M$2M$878K$0
Net Debt-$108M-$44M-$4M-$6M-$17M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms